fluoromisonidazole has been researched along with Experimental Mammary Neoplasms in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayers, GD; Fluckiger, JU; Peterson, TE; Tantawy, MN; Whisenant, JG; Yankeelov, TE | 1 |
| Bentzen, L; Grönroos, T; Hansen, SB; Horsman, MR; Keiding, S; Overgaard, J | 1 |
| Bentzen, L; Eskola, O; Grönroos, T; Haaparanta, M; Horsman, MR; Keiding, S; Marjamäki, P; Minn, H; Murata, R; Solin, O | 1 |
| Cumming, P; Horsman, MR; Keiding, S; Munk, OL; Sørensen, M | 1 |
| Sinesi, MS; Stone, HB | 1 |
| Cherif, A; Gretzer, MB; Kim, EE; Li, C; Podoloff, DA; Wallace, S; Yang, DJ | 1 |
| Fujibayashi, Y; Lewis, JS; McCarthy, DW; McCarthy, TJ; Welch, MJ | 1 |
| Higuchi, T; Ilgan, S; Kim, EE; Liu, CW; Oh, CS; Podoloff, DA; Yang, DJ; Zareneyrizi, F | 1 |
| Chin, LK; Hofstrand, PD; Rasey, JS; Tewson, TJ | 1 |
| Griffiths, JR; Maxwell, RJ; Workman, P | 1 |
10 other study(ies) available for fluoromisonidazole and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Reproducibility of static and dynamic (18)F-FDG, (18)F-FLT, and (18)F-FMISO MicroPET studies in a murine model of HER2+ breast cancer.
Topics: Animals; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Kinetics; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Misonidazole; Models, Biological; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Reproducibility of Results | 2013 |
Assessment of hypoxia in experimental mice tumours by [18F]fluoromisonidazole PET and pO2 electrode measurements. Influence of tumour volume and carbogen breathing.
Topics: Animals; Autoradiography; Carbon Dioxide; Cell Hypoxia; Electrodes; Female; Fluorine Radioisotopes; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Oxygen; Tomography, Emission-Computed | 2002 |
Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma.
Topics: Animals; Cell Hypoxia; Female; Fluorine Radioisotopes; Mammary Neoplasms, Experimental; Metabolic Clearance Rate; Mice; Misonidazole; Nitroimidazoles; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution | 2004 |
Effect of intratumoral heterogeneity in oxygenation status on FMISO PET, autoradiography, and electrode Po2 measurements in murine tumors.
Topics: Animals; Autoradiography; Carcinoma, Squamous Cell; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Oxygen Consumption; Partial Pressure; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals | 2005 |
Testing of new hypoxic cell sensitizers in vivo.
Topics: Animals; Drug Evaluation, Preclinical; Etanidazole; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents | 1982 |
Development of F-18-labeled fluoroerythronitroimidazole as a PET agent for imaging tumor hypoxia.
Topics: Animals; Autoradiography; Cell Hypoxia; Contrast Media; Female; Fluorine Radioisotopes; Male; Mammary Neoplasms, Experimental; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Rabbits; Rats; Rats, Inbred F344; Tissue Distribution; Tomography, Emission-Computed | 1995 |
Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model.
Topics: Animals; Autoradiography; Cell Hypoxia; Coordination Complexes; Drug Evaluation, Preclinical; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Misonidazole; Organometallic Compounds; Oxygen; Thiosemicarbazones; Tissue Distribution; Tumor Cells, Cultured | 1999 |
Noninvasive assessment of tumor hypoxia with 99mTc labeled metronidazole.
Topics: Animals; Autoradiography; Cell Hypoxia; Cysteine; Female; Fluorine Radioisotopes; Iodine Radioisotopes; Mammary Neoplasms, Experimental; Metronidazole; Microelectrodes; Misonidazole; Neovascularization, Pathologic; Organotechnetium Compounds; Oxygen; Radiation-Sensitizing Agents; Radionuclide Imaging; Rats; Rats, Inbred F344; Tissue Distribution | 1999 |
Characterization of [18F]fluoroetanidazole, a new radiopharmaceutical for detecting tumor hypoxia.
Topics: Animals; Binding Sites; Blood-Brain Barrier; Cell Hypoxia; Chromatography, High Pressure Liquid; Contrast Media; Cricetinae; Cricetulus; Etanidazole; Female; Fibroblasts; Fibrosarcoma; Fluorine Radioisotopes; Glioma; Lung; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Neoplasms, Experimental; Oxygen; Radionuclide Imaging; Radiopharmaceuticals; Rats; Sarcoma, Experimental; Time Factors; Tissue Distribution; Tumor Cells, Cultured | 1999 |
Demonstration of tumor-selective retention of fluorinated nitroimidazole probes by 19F magnetic resonance spectroscopy in vivo.
Topics: Animals; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Sarcoma, Experimental | 1989 |